Conference and Exhibition on Drug On 06 May 2011

On 06 May 2011, STADA-VN has participated in the Conference and Exhibition on Drug held by Ho Chi Minh City Health Department together with more than 40 pharmaceutical manufacturers.

image017

In the exhibition, STADA-VN has introduced to the delegates about 90 items in product list. Most of products of STADA-VN have been highly appreciated

About STELLA

STELLAPHARM is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, anti-viral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.

The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.

Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An Town, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: info@stellapharm.com | W: www.stellapharm.com

You May like

28 Oct 2025

STELLAPHARM’S CERTIFIED ISO 14001:2015 (ENVIRONMENTAL MANAGEMENT SYSTEM), ISO 45001:2018 (OCCUPATIONAL HEALTH AND SAFETY MANAGEMENT SYSTEM) COMPLIANCE BY BUREAU VERITAS

Stellapharm J.V. Co., Ltd. – Branch 1 has just been certified by Bureau Veritas Certification – an international certification organization in the field of inspection, testing and certification – compliance with two international standards ISO 14001: 2015 and ISO 45001: 2018 for all pharmaceutical production, distribution and export activities. As a business operating in health

22 Oct 2025

STELLAPHARM ACHIEVED CROATIAN – GMP CERTIFICATION

On July 18, 2025, STELLAPHARM J.V. Co., Ltd. – Branch 1 achieved the EU – GMP (Good Manufacturing Practice) certification issued by the competent authority, the Croatian Agency for Medicinal Products and Medical Devices (HALMED) and the information is published on the EudraGMDP database of the European Union. Achieving this certification not only enhances the